1. Wildonger, K. J., Leanza, W. S., Miller, T. W., Christensen, B. G.: N-acetimidoyl and N-formimidoyl thienamycin — chemically stable, broad spectrum derivatives. 19th Interscience Conference on Antimicrob. Agents Chemother., Boston 1979, Abstr. no. 232.
2. Braveny, I., Dickert, H., Machka, K. Antibakterielle Aktivität von Cefotaxim im Vergleich mit sieben Cephalosporinen. Infection 7 (1979) 231–236.
3. Rodriguez, A., Olay, T., de Vicente, M. V. Thienamycin:In vitro studies. In:Nelson, J. D., Grassi, C. (eds.): Current Chemotherapy. Proceedings of the 11th International Congress of Chemotherapy. American Society for Microbiology, Washington D. C., Vol. 1, 1980, pp. 492–494.
4. Romagnoli, M. F., Fu, K. P., Neu, H. C. Antibacterial activity of thienamycin compared with β-lactamase-stable compounds against multiresistant bacteria. In:Nelson, J. D., Grassi, C. (eds.): Current Chemotherapy. Proceedings of the 11th International Congress of Chemotherapy. American Society for Microbiology, Washington D. C., Vol. 1, 1980, pp. 494–495.
5. Wise, R., Andrews, J. M., Patel, N. N-formimidoyl thienamycin a novel β-lactam: anin vitro comparison with other β-lactam antibiotics. J. Antimicrob. Chemother. 7 (1981) 521–529.